Protagenic Therapeutics (PTIX) — Tangible Net Worth Ratio
Protagenic Therapeutics (PTIX) has a Tangible Net Worth Ratio of 100.0% as of December 2024. This metric is calculated by deducting intangible assets ($0.00) from net assets ($1.01 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore PTIX net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Protagenic Therapeutics Tangible Net Worth Ratio (1995–2024)
This chart shows how Protagenic Therapeutics's Tangible Net Worth Ratio has changed across 21 annual periods from 1995 to 2024. As of December 2024, the ratio stands at 100.0%, reflecting net assets of $1.01 Million with intangible assets of $0.00 USD. For live market cap and overall valuation, see Protagenic Therapeutics stock valuation.
Annual Tangible Net Worth Ratio for Protagenic Therapeutics (1995–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Protagenic Therapeutics from 1995 to 2024, covering 21 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore Protagenic Therapeutics capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 100.0% | $1.01 Million | $0.00 | $1.96 Million | ▲ +0.0 pp |
| 2023 | 100.0% | $3.67 Million | $0.00 | $4.32 Million | ▲ +0.0 pp |
| 2022 | 100.0% | $6.92 Million | $0.00 | $8.04 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $9.94 Million | $0.00 | $11.06 Million | ▲ +0.0 pp |
| 2017 | 100.0% | $1.22 Million | $0.00 | $1.78 Million | ▲ +0.0 pp |
| 2016 | 100.0% | $2.48 Million | $0.00 | $3.16 Million | ▲ +37.7 pp |
| 2010 | 62.3% | $8.17 Million | $3.08 Million | $19.34 Million | ▼ -9.1 pp |
| 2009 | 71.4% | $25.35 Million | $7.25 Million | $44.60 Million | ▼ -5.7 pp |
| 2008 | 77.1% | $54.65 Million | $12.51 Million | $78.76 Million | ▼ -19.3 pp |
| 2007 | 96.4% | $16.86 Million | $599.00K | $23.96 Million | ▼ -3.6 pp |
| 2006 | 100.0% | $1.22 Million | $0.00 | $5.49 Million | ▲ +0.0 pp |
| 2004 | 100.0% | $2.74 Million | $0.00 | $6.95 Million | ▲ +0.0 pp |
| 2003 | 100.0% | $4.98 Million | $0.00 | $13.74 Million | ▲ +0.0 pp |
| 2002 | 100.0% | $12.87 Million | $0.00 | $21.53 Million | ▲ +0.0 pp |
| 2001 | 100.0% | $13.57 Million | $0.00 | $23.27 Million | ▲ +0.0 pp |
| 2000 | 100.0% | $13.86 Million | $0.00 | $22.92 Million | ▲ +0.0 pp |
| 1999 | 100.0% | $13.27 Million | $0.00 | $22.93 Million | ▲ +0.0 pp |
| 1998 | 100.0% | $13.95 Million | $0.00 | $21.48 Million | ▲ +0.0 pp |
| 1997 | 100.0% | $13.30 Million | $0.00 | $15.77 Million | ▲ +0.0 pp |
| 1996 | 100.0% | $7.04 Million | $0.00 | $12.57 Million | ▲ +0.0 pp |
| 1995 | 100.0% | $7.51 Million | $0.00 | $11.08 Million | — |